Obesity
📧 Sign up to get email alerts when something new happens for Obesity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-10-31Clinical Trial Update: Behavioral Weight Loss and Stigma Reduction [NA]
A completed clinical trial conducted by the University of Pennsylvania focused on behavioral weight loss and stigma reduction in individuals…
-
EMA withdrawal · 2022-10-28EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines
EMA confirms a recommendation to withdraw marketing authorisations for amfepramone medicines used for weight loss due to safety concerns.
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: Semaglutide to Reduce Atrial Fibrillation Burden [Phase 4]
Phase 4 clinical trial investigating semaglutide to reduce atrial fibrillation burden is currently suspended.
-
CLINICAL_TRIALS research · 2022-10-25Clinical Trial Update: Pilot Study of Time Restricted Feeding as a Weight Loss Intervention [NA]
Pilot study of time-restricted feeding as a weight loss intervention for obesity; completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-24Clinical Trial Update: The University of Michigan OWL (Online Wellness and Lifestyle) Study [Phase 1, Phase 2]
A clinical trial update for the University of Michigan OWL study investigating obesity with Phase 1 and Phase 2 completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2022-10-19Clinical Trial Update: Cognition and Magnetic Resonance Imaging of Brain Inflammation in Obesity [NA]
A completed clinical trial investigating cognition and brain inflammation in obesity, with posted results in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: Multicenter Endoscopic Sleeve Gastrectomy (ESG) Trial (MERIT Trial) [NA]
The MERIT multicenter trial evaluating endoscopic sleeve gastrectomy for obesity-related indications has completed with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2022-10-17Clinical Trial Update: Fatty Liver Disease in Obese Children [Phase 1, Phase 2]
Phase 1/2 clinical trial update on fatty liver disease in obese children has completed testing under Nemours Children's Clinic.
-
CLINICAL_TRIALS trial_result · 2022-10-14Clinical Trial Update: TOSS Feasibility + Fitbit Community = Reduced Obesity in Older Black Women [NA]
A completed clinical trial explored a TOSS feasibility study combined with Fitbit use to reduce obesity in older Black women, with results p…
-
CLINICAL_TRIALS trial_result · 2022-10-10Clinical Trial Update: Intragastric Injections of Botox for the Treatment of Obesity [Phase 2]
Phase 2 clinical trial update for intragastric injections of Botox as a treatment for obesity (Morbid Obesity).
-
CLINICAL_TRIALS trial_result · 2022-10-06Clinical Trial Update: Trial of Roflumilast in Asthma Management (TRIM) [Phase 2]
A Phase 2 trial update on roflumilast for asthma management has completed, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-29Clinical Trial Update: Effects of Sodium-glucose Co-transporter-2( SGLT-2 ) Inhibition on Sympathetic Nervous System Activity in Humans [Phase 4]
Phase 4 trial update evaluating the effects of SGLT-2 inhibition on sympathetic nervous system activity in humans with metabolic syndrome an…
-
CLINICAL_TRIALS trial_result · 2022-09-29Clinical Trial Update: Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension [Phase 4]
Phase 4 clinical trial update examining sympathoinhibition as a preferred second-line treatment for obesity-related hypertension.
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: The Lowering Weight in Severe Obesity by Embolization of the Gastric Artery Trial [NA]
A completed clinical trial investigating gastric artery embolization for weight reduction in morbid obesity; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-26Clinical Trial Update: Reporting Patient Generated Health Data and Patient Reported Outcomes With Health Information Technology [NA]
Clinical trial update on reporting patient-generated health data and patient-reported outcomes using health IT for obesity; results complete…
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: Neuronal and Behavioral Effects of Implicit Priming in Obese Individuals [NA]
A completed clinical trial studying neuronal and behavioral effects of implicit priming in obese individuals, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-01Clinical Trial Update: Adapted ACHIEVE Curriculum for Community Mental Health Settings [NA]
Clinical trial update on adapted ACHIEVE curriculum implemented in community mental health settings; study related to obesity and severe men…
-
CLINICAL_TRIALS trial_result · 2022-08-30Clinical Trial Update: Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes [NA]
Clinical trial update for Gelesis100 in overweight and obese adults, with and without Type 2 diabetes, completed with results posted.
-
FDA approval · 2022-08-24FDA Approved: WEGOVY — Supplemental Application (Novo Nordisk)
The FDA approved Novo Nordisk's supplemental application for Wegovy (semaglutide). This action expands its labeling to support chronic weigh…
-
CLINICAL_TRIALS trial_result · 2022-08-22Clinical Trial Update: Feasibility Trial of the iAMHealthy Intervention [NA]
Completed feasibility trial of the iAMHealthy intervention for obesity in rural populations; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Cardiovascular Effects of GLP-1 Receptor Activation [Phase 4]
Phase 4 trial update evaluating cardiovascular effects of GLP-1 receptor activation in obesity and prediabetes.
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Liraglutide for HIV-associated Neurocognitive Disorder [Phase 4]
Phase 4 trial of liraglutide for HIV-associated neurocognitive disorder was terminated.
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes [Phase 4]
Phase 4 trial update examining whether liraglutide reduces endoplasmic reticulum stress in obese patients with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2022-07-20Clinical Trial Update: Efficacy of Oral Semaglutide in Overweight or Obesity [Phase 4]
Phase 4 trial update assessing the efficacy of oral semaglutide in individuals with overweight or obesity.
-
CLINICAL_TRIALS research · 2022-07-15Clinical Trial Update: Exercise Intolerance in Elderly Patients With HFpEF(Heart Failure With Preserved Ejection Fraction) [NA]
A completed clinical trial evaluating exercise intolerance in elderly patients with heart failure with preserved ejection fraction (HFpEF).